Literature DB >> 21251539

Hemoglobin variability as a predictor of mortality: What's a practitioner to do?

Jay B Wish.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21251539     DOI： 10.1053/j.ajkd.2010.11.004

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN： 0272-6386            Impact factor:   8.860


× No keyword cloud information.
  3 in total

1.  The MAINTAIN study--managing hemoglobin variability with darbepoetin alfa in dialysis patients experiencing a severe drop in hemoglobin.

Authors:  Bruno Watschinger; Hermann Salmhofer; Sabine Horn; Ulrich Neyer; Tatjana Wiesinger; Martin Wiesholzer; Helmut Erb; Christine Jaeger; Margit Hemetsberger; Alexander R Rosenkranz
Journal:  Wien Klin Wochenschr       Date:  2013-01-09       Impact factor: 1.704

2.  Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients.

Authors:  Do Hyoung Kim; Young-Ki Lee; Juhee Kim; Hayne Cho Park; Kyu Sang Yun; AJin Cho; Jong-Woo Yoon; Ja-Ryong Koo; Jung-Woo Noh
Journal:  Kidney Res Clin Pract       Date:  2021-08-31

3.  Haemoglobin variability and all-cause mortality in haemodialysis patients: A systematic review and meta-analysis.

Authors:  Lingfei Zhao; Chenxia Hu; Jun Cheng; Ping Zhang; Hua Jiang; Jianghua Chen
Journal:  Nephrology (Carlton)       Date:  2019-02-28       Impact factor: 2.506
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.